By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Purdue Pharmaceuticals L.P. 

4701 Purdue Drive

Wilson  North Carolina  27893  U.S.A.
Phone: 252-265-1900 Fax: 252-243-2533


Purdue Pharmaceuticals L.P. is a 200,000-square-foot, state-of-the-art pharmaceutical manufacturing, packaging, and distribution facility that produces oral solid dosage tablets and also distributes oral liquids and sterile injectibles for Purdue Pharma L.P., an independent associated company headquartered in Stamford, CT. These privately held companies, founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care, are dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The companies have long been known for their pioneering research on persistent pain, a principal cause of human suffering.

Purdue Pharma also has a growing line of non-prescription products including laxatives, microbicides, and nutraceuticals. The company is dedicated to serving the evolving needs of healthcare providers, patients, and caregivers with prescription and non-prescription medicines. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.

Purdue Pharma has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain. Its sales, marketing, and medical education professionals provide the healthcare community with comprehensive educational materials and programs relating to pain management.

In 1993, Purdue Pharma established Partners Against Pain® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy. Purdue has also assumed a leading role in addressing the serious public health problem of prescription drug abuse, supporting programs intended to help stem abuse.

Key Statistics

Ownership: Private

Web Site: Purdue Pharma L.P.
Employees: 195



Infinity Pharma 

Company News
National Sheriffs’ Association And Purdue Pharma L.P. Announce Additional Funding For Life-Saving Opioid Overdose Initiative 6/26/2017 11:42:02 AM
Dr. Craig Landau Appointed President And CEO Purdue Pharma L.P. 6/22/2017 12:20:44 PM
Ohio Sues Purdue Pharma L.P. Over Oxycontin’s Deadly Impact 6/1/2017 9:17:28 AM
Purdue Pharma L.P. Names Josie Martin Head Of Corporate Affairs & Communications 4/24/2017 6:21:09 AM
Purdue Pharma L.P. Announces Hire Of Carrie Chomiak To Lead Over-The-Counter Franchise 4/21/2017 7:55:28 AM
Intellipharmaceutics (IPCI) Announces Patent Litigation By Purdue Pharma L.P. Against Its Rexista Abuse-Deterrent Extended-Release Oxycodone 4/10/2017 10:22:33 AM
Senator Launches Investigation Into Top Opioid Makers—Purdue Pharma L.P., Janssen/Johnson & Johnson (JNJ), INSYS, Mylan (MYL) And Depomed (DEPO) 3/29/2017 7:07:04 AM
Purdue Pharma L.P. Highlights Research From Multiple Studies At AMCP Managed Care & Specialty Pharma Annual Meeting 2017 3/29/2017 6:56:39 AM
INSYS Names Purdue Pharma L.P. Exec As New CEO, Effective April 17 3/27/2017 7:20:18 AM
Shionogi And Purdue Pharma L.P. Establish Alliance For Joint U.S. Commercialization Of Naldemedine 12/19/2016 10:01:55 AM